Race Reporting and Representation Remain Disparate in Pivotal Cancer Trials
Researchers evaluated the frequency of race reporting and race representation in pivotal drug trials that are used to establish standards of care in oncology treatment.
Oncology
FDA Warns of “Cure-All” Products That Actually Contain Bleach
The FDA is warning consumers to stop using products known as Miracle or Master Mineral Solution, Miracle Mineral Supplement, MMS, Chlorine Dioxide Protocol, and Water Purification Solution due to numerous reports of significant health issues.
Biosimilars Mvasi, Kanjinti Now Available in the US
Mvasi is a biosimilar to Avastin; Kanjinti is a biosimilar to Herceptin.
WHO Updates List of Essential Medication for 2019
The World Health Organization (WHO) has updated the WHO Model List of Essential Medicines for 2019.
FDA Approves Novel Therapy for Relapsed, Refractory Multiple Myeloma
Continued approval of Xpovio for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
Fluorouracil Injection Recalled Due to Glass Particulate
No reports of adverse events have been received at this time, as per the Company.
Biosimilar Zirabev Gets FDA Approval for 5 Types of Cancer
The FDA has approved Zirabev (bevacizumab-bvzr; Pfizer), a biosimilar to Avastin (bevacizumab; Genentech).
Number of Cancer Survivors Set to Top 22 Million by 2030
The number of cancer survivors is projected to increase to more than 22.1 million by Jan. 1, 2030, based on growth and aging of the population alone.
Emotionally Responsive Virtual Coach Helps Address Patient Concerns in New Simulation
Kognito, a health simulation company, is applying its simulation technology to patient education, to address a gap in patient knowledge.
Chemobrain: Experts Weigh in on Very Real — and Growing — Problem
Clinicians should know that chemotherapy-induced cognitive impairment, chemobrain, chemofog, or whatever you want to call it is a real phenomenon.
